Oncotype DX could reduce chemotherapy in node-positive breast cancer, studies find
This article was originally published in Clinica
Executive Summary
Genomic Health's Oncotype DX breast cancer recurrence score could help select more appropriate treatment for node-positive breast cancer patients, two studies have found.